INTERNATIONAL PATENT: BLUEPRINT MEDICINES CORPORATION FILES APPLICATION FOR "SALT AND SOLID FORMS OF AN EGFR INHIBITOR"

GENEVA, April 21 -- BLUEPRINT MEDICINES CORPORATION (45 Sidney StreetCambridge, MA 02139) filed a patent application (PCT/US2024/050702) for "SALT AND SOLID FORMS OF AN EGFR INHIBITOR" on Oct 10, 2024. With publication no. WO/2025/080786, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DE PAOLIS, Omar (c/o Blueprint Medicines Corporation45 Sidney StreetCambridge, MA 02139), HEINRICH, Brian (c/o Blueprint Medicines Corporation45 Sidney StreetCambridge, MA 02139), KAUFFMAN, Goss Stryker (c/o Blueprint Medicines Corporation4...